BackFusion Pharmaceuticals Overview

Fusion Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for FUSN.

Quarterly Cost of Revenue

$361000.00
↓ 97.73% YoY

As of Mar 31, 2024

Annual Cost of Revenue (TTM)

$2.70M
↓ 83.01% YoY

Trailing 12 months ending Mar 31, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin